Transgene expression of plasmid DNAs directed by viral or neural promoters in the rat brain

Molecular Brain Research

Volumn 46, Issue 1-2, 1997, Pages 91-99

  Hannas Djebbara, Zahia ^a   Didier Bazès, Marianne ^a   Sacchettoni, Sergio ^a   Prod'hon, Catherine ^a   Jouvet, Michel ^a   Belin, Marie Françoise ^a   Jacquemont, Bernard ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

GFAP promoter; HCMV promoter; LacZ; NSE promoter; Plasmid DNA

Indexed keywords

ENOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; PLASMID DNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN; CEREBELLUM; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE INSERTION; GENE TRANSFER; HISTOCHEMISTRY; HUMAN CYTOMEGALOVIRUS; IMMUNOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; THALAMUS; TRANSGENE; VIRUS;

ANIMALS; BRAIN; DNA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSGENES; VIRAL PHYSIOLOGY;

EID: 0030978943     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00276-8     Document Type: Article

References (50)

1. Acsadi, G., Jiao, S.S., Jani, A., Duke, D., Williams, P., Wang, C. and Wolff, J.A., Direct gene transfer and expression into rat heart in vivo, New Biol., 3 (1991) 71-81.
2. Allfrey, V. and Mirsky, A.E., Some aspects of the desoxyribonuclease activities of animal tissues, J. Gen. Physiol., 36 (1952) 227-241.
3. Alliot, F. and Pessac, B., Astrocytic cell clones derived from established cultures of 8 day postnatal mouse cerebella, Brain Res., 306 (1994) 283-291.
4. Andersen, J.K., Garber, D.A., Meaney, C.A. and Breakefield, X.O., Gene transfer into mammalian central nervous system using Herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter, Hum. Gene Therap., 3 (1992) 487-499.
5. Baron, M., Reynes, J.P., Stassi, D. and Tibary, G., A selectable bifunctional β-galactosidase phléomycin-resistance fusion protein as a potential marker for eukaryotic cells, Gene, 114 (1992) 239-243.
6. Baskar, J.F., Smith, P.P., Nilaver, G., Jupp, R.A., Hoffmann, S., Peffer, N.J., Tenney, D.J., Colberg-Poley, A.M., Ghazal, P. and Nelson, J.A., The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice, J. Virol., 70 (1996) 3207-3214.
7. Besnard, F., Brenner, M., Nakatani, Y., Chao, R., Purohit, H.J. and Freese, E., Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein, J. Biol. Chem., 266 (1991) 18877-18883.
8. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.P., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc. Natl. Acad. Sci. USA, 92 (1995) 7297-7301.
9. Breakefield, X.O. and Deluca, N.A., Herpes simplex virus for gene delivery to neurons, New Biol., 3 (1991) 203-218.
10. Brenner, M., Kisseberth, W.C., Su, Y., Besnard, F. and Messing, A., GFAP promoter directs astrocyte-specific expression in transgenic mice, J. Neurosci., 14 (1994) 1030-1037.
11. Brenner, M., Structural and transcriptional regulation of the GFAP gene, Brain Pathol., 4 (1994) 245-257.
12. Calvo, J.L., Carbonell, A.L. and Boya, J., Co-expression of glial fibrillary acidic protein and vimentin in reactive astrocytes following brain injury in rats, Brain Res., 566 (1991) 333-336.
13. Cao, L., Zheng, Z.C., Zhao, Y.C., Jiang, Z.H., Liu, Z.G., Chen, S.D., Zhou, C.F. and Liu, X.Y., Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofectin complex, Hum. Gene Therap., 6 (1995) 1497-1501.
14. Crystal, R.G., Transfer of genes to humans: early lessons and obstacles to success, Science, 270 (1995) 404-410.
15. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H. and Blaese, R.M., In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors, Science, 256 (1992) 1550-1552.
16. Davar, G., Kramer, M.F., Garber, D., Roca, A.L., Andersen, J.K., Bebrin, W., Coen, D.M., Kosz-Vnenchak, M., Knipe, D.M., Breakefield, X.O. and Isacson, O., Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors, J. Comp. Neur., 339 (1994) 3-11.
17. Davis, H.L., Whalen, R.G. and Demeneix, B.A., Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression, Hum. Gen. Therap., 4 (1993) 151-159.
18. Davis, H.L., Demeneix, B.A., Quantin, B., Coulombe, J. and Whalen, R.G., Plasmid DNA is superior to viral vectors for direct gene transfer into adult skeletal muscle, Hum. Gen. Therap., 4 (1993) 733-740.
19. Engelhardt, J.F., Ye, X., Doranz, B. and Wilson, J.M., Ablation of E2A in recombinant adenovirus improves transgene persistence and decrease inflammatory response in mouse liver, Proc. Natl. Acad. Sci. USA, 91 (1994) 6196-6200.
20. Ezzeddine, Z.D., Martuza, R.L., Platika, D., Short, M.P., Malick, A., Choi, B. and Breakefield, X.O., Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the Herpes simplex virus thymidine kinase gene, New Biol., 3 (1991) 608-614.
21. Forss-Petter, S., Danielson, P.E., Catsisas, S., Battenberg, E., Price, J., Nerenberg, M. and Sutcliffe, J.G., Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control, Neuron, 5 (1990) 187-197.
22. Freese, A., Geller, A.I. and Neve, R., HSV-1 vector mediated neuronal gene delivery, Bioch. Pharm., 40 (1990) 2189-2199.
23. Galou, M., Pournin, S., Ensergueix, D., Ridet, J.L., Tchelingerian, J.L., Lossouarn, L., Privat, A., Babinet, C. and Dupouey, P., Normal and pathological expression of GFAP promoter elements in trangenic mice, Glia, 12 (1994) 281-293.
24. Graham, F.L. and van der Eb, A.J., A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology, 52 (1973) 456-467.
25. Graus, F., Cordon-Cardo, C. and Posner, J.B., Neuronal antinuclear antibody in sensory neuronopathy from lung cancer, Neurology, 35 (1985) 538-543.
26. Hickman, M.A., Malone, R.W., Lehmann-Bruinsma, K., Sih, T.R., Knoell, D., Szoka, F.C., Walzem, R., Carlson, D.M. and Powell, J.S., Gene expression following direct injection of DNA into liver, Hum. Gene Therap., 5 (1994) 1477-1484.
27. Holt, C.E., Garlick, N. and Cornel, E., Lipofection of cDNAs in the embryonic vertebrate central nervous system, Neuron, 4 (1990) 203-214.
28. Jirikowski, G.F., Sanna, P.P., Maciejewski-Lenoir, D. and Bloom, F.E., Reversal of diabetes insipidus in brattleboro rats: intrahypothalamic injection of vasopressin mRNA, Science, 255 (1992) 996-998.
29. Johnson, W.B., Ruppe, M.D., Rockenstein, E.M., Price, J., Sarthy, V.P., Verderber, L.C. and Mucke, L., Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-LacZ transgenes, Glia, 13 (1995) 174-184.
30. Kaneko, R. and Sueka, N., Tissue-specific versus cell type-specific expression of the glial fibrillary acidic protein, Proc. Natl. Acad. Sci. USA, 90 (1993) 4698-4702.
31. Kaplitt, M.G., Pfaus, J.G., Kleopoulos, S.P., Hanlon, B.A., Rabkin, S.D. and Pfaff, D.W., Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector, Mol. Cell Neurosci., 2 (1991) 320-330.
32. Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D.H., Alvira, M., Buttrick, P.M. and Leinwand, L.A., The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer, Gene Therap., 1 (1994) 395-402.
33. Ledley, F.D., Nonviral gene therapy: the promise of genes as pharmaceutical products, Hum. Gene Therap., 6 (1995) 1129-1144.
34. Lokensgard, J.R., Bloom, D.C., Dobson, A.T. and Feldman, L.T., Long-term promoter activity during herpes simplex virus latency, J. Virol., 68 (1994) 7148-7158.
35. Maciejewski-Lenoir, D., Jirikowski, G.F., Sanna, P.P. and Bloom, F.E., Reduction of exogenous vasopressin RNA poly(A) tail lenght increases its effectiveness in transiently correcting diabetes insipidus in brattleboro rat, Proc. Natl. Acad. Sci. USA, 90 (1993) 1435-1439.
36. Madaio, M.P., Hodder, S., Schwartz, B. and Stollar, B.D., Responsiveness of autoimmune and normal mice to nucleic acid antigens, J. Immunol., 132 (1984) 572-876.
37. Massod, K., Besnard, F., Su, Y. and Brenner, M., Analysis of a fragment of the human glial fibrillary acidic protein gene that directs astrocyte-specific transcription, J. Neurochem., 61 (1993) 160-166.
38. Miura, M., Tamura, T. and Mikoshiba, K., Cell-specific expression of the mouse glial fibrillary acidic protein gene: identification of the cis- and trans-acting promoter elements for astrocyte-specific expression, J. Neurochem., 55 (1990) 1180-1188.
39. Mucke, L., Oldstone, M.B., Morris, J.C. and Nerenberg, M.I., Rapid activation of astrocyte-specific expression of GFAP-LacZ transgene by focal injury, New Biol., 3 (1991) 465-474.
40. Nabel, E.G., Gordon, D., Yang, Z.Y., Xu, L., San, H., Plautz, G.E., Wu, B.Y., Huang, L. and Nabel, G.J., Gene transfe in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localisation, Hum. Gene. Therap., 3 (1992) 649-656.
41. Neve, R.L., Adenovirus vectors enter the brain, Trends Neurosci., 16 (1993) 251-253.
42. Ono, T., Fujino, Y., Tsuchiya, T. and Tsuda, M., Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells, Neurosci. Lett., 117 (1990) 259-263.
43. Sakimura, K., Kushiya, E., Ogura, A., Kudo, Y., Katagiri, T. and Takahashi, Y., Upstream and intron regulatory regions for expression of the rat neuron-specific enolase gene, Brain Res., 28 (1995) 19-28.
44. Sancho-Tello, M., Valles, S., Montoliu, C., Renau-Piqueras, J. and Guerri, C., Developmental pattern of GFAP and vimentin gene expression in rat brain and in radial glial cultures, Glia, 15 (1995) 157-166.
45. Sarkar, S. and Cowan, N.J., Intragenic sequences affect the expression of the gene encoding glial fibrillary acidic protein, J. Neurochem., 57 (1991) 675-684.
46. Szabo, A., Dalmau, J. and Manley, G., HuD, a paraneoplastic encephalomyelitis antigen contains RNA binding domains and is homologous to Elav and sex-lethal, Cell, 67 (1991) 325-333.
47. Tardy, M., Pages, C., Riol, H., Leprince, G., Rataboul, P., Charriere-Bertrandc and Munez, J., Developmental expression of the glial fibrillary acidic protein mRNA in the central nervous system and in cultured astrocytes, J. Neurochem., 52 (1989) 162-167.
48. Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner, P.L., Direct gene transfer into mouse muscle in vivo, Science, 247 (1990) 1465-1468.
49. Wood, M.J.A., Byrnes, A.P., Pfaff, D.W., Rabkin, S.D. and Charlton, H.M., Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors, Gene Therap., 1 (1994) 283-291.
50. Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gonczol, E. and Wilson, J.M., Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy, Proc. Natl. Acad. Sci. USA, 91 (1994) 4407-4411.